Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06490211

The Research Value of Multi-omics and Multi-modal Information in the Diagnosis and Treatment of Urinary System Tumors

Obtain puncture or surgically removed tumor tissue samples from patients with urinary tract tumors and perform RNA-sequencing, Single-cell RNA-sequence, Spatial Transcriptomics, Proteomics, and Intratumoral Microbiome.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Union Hospital,Tongji Medical College,Huazhong University of Science and Technology

Wuhan, Hubei, 430000, China

Location status: Recruiting

Location contact

Lian Yang

CONTACT

[email protected]

18986273791

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients were treated for bladder cancer, kidney cancer, and prostate cancer in Wuhan Union Hospital from January 2024 to January 2026;
  • Aged > 18 years old;
  • Urinalysis, urine exfoliated cells, ultrasound, CT, and MR examinations indicated the above tumors;
  • Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.

Exclusion criteria

  • Poor image quality;
  • Incomplete clinical data or loss of follow-up;
  • Presence of another primary malignant tumor other than urinary tract tumor;
  • Unclear pathological diagnosis

Treatment and study plan

Primary outcomes

  1. progression-free survival

    Time frame: 2 years

Study contacts

Contact information is provided by the study sponsor or research team.

Lian Yang

CONTACT

[email protected]

18986273791

Sponsors and collaborators

Lead sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Other

Registry information

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Jul 8, 2024
Registry last updated
Jul 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.